InsiderClue
Insiders · Profile

GORDON CARL L

Director at BlossomHill Therapeutics · Director at Scribe Therapeutics · Director at Compass Therapeutics · and 11 more. Filing since 8 Feb 2011. CIK 0001282930

BLSM BlossomHill Therapeutics, Inc. Director · 1 trade SCTX Scribe Therapeutics, Inc. Director · 1 trade CMPX Compass Therapeutics, Inc. Director · 10 trades MBX MBX Biosciences, Inc. Director · 3 trades KROS Keros Therapeutics, Inc. Director · 2 trades AVBP ArriVent BioPharma, Inc. Director · 1 trade ACET Adicet Bio, Inc. Director · 2 trades ORIC Oric Pharmaceuticals, Inc. Director · 15 trades ALEC Alector, Inc. Director · 1 trade XFOR X4 Pharmaceuticals, Inc Director · 1 trade RNAC Cartesian Therapeutics, Inc. Director · 1 trade NTLA Intellia Therapeutics, Inc. Director · 1 trade AMRN AMARIN CORP PLC\UK Director · 21 trades PCRX Pacira BioSciences, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
BLSM BlossomHill Therapeutics, Inc.
10 Aug 2026
Director
Bought
625,000
$10.00M
29.9%
SCTX Scribe Therapeutics, Inc.
27 Jul 2026
Director
Bought
1,000,000
$15.00M
287%
CMPX Compass Therapeutics, Inc.
9 Apr 2025
Director
Sold at will
3,571,428
$5.68M
100%
MBX MBX Biosciences, Inc.
18 Feb 2025
Director
Bought
143,170
$1.55M
4.6%
MBX MBX Biosciences, Inc.
14 Feb 2025
Director
Bought
47,502
$468.79K
1.5%
MBX MBX Biosciences, Inc.
16 Sep 2024
Director
Bought
750,000
$12.00M
31.1%
KROS Keros Therapeutics, Inc.
13 Aug 2024
Director
Sold at will
250,000
$11.00M
67.7%
AVBP ArriVent BioPharma, Inc.
30 Jan 2024
Director
Bought
444,444
$8.00M
41.6%
ACET Adicet Bio, Inc.
25 Jan 2024
Director
Bought
3,125,000
$7.50M
71.0%
ACET Adicet Bio, Inc.
27 Jun 2023
Director
Bought
875,000
$1.83M
18.2%
CMPX Compass Therapeutics, Inc.
8 Nov 2022
Director
Bought
402,000
$1.29M
2.7%
CMPX Compass Therapeutics, Inc.
13 May 2022
Director
Bought
30,722
$76.50K
0.2%
CMPX Compass Therapeutics, Inc.
12 May 2022
Director
Bought
97,094
$228.17K
0.7%
CMPX Compass Therapeutics, Inc.
11 May 2022
Director
Bought
64,700
$115.81K
0.4%
CMPX Compass Therapeutics, Inc.
10 May 2022
Director
Bought
24,447
$39.12K
0.2%
CMPX Compass Therapeutics, Inc.
9 May 2022
Director
Bought
90,712
$141.51K
0.6%
CMPX Compass Therapeutics, Inc.
6 May 2022
Director
Bought
10,200
$16.63K
0.1%
CMPX Compass Therapeutics, Inc.
4 Nov 2021
Director
Bought
5,357,143
$18.75M
58.6%
ORIC Oric Pharmaceuticals, Inc.
30 Mar 2021
Director
Sold, plan not stated
27,869
$666.91K
1.2%
ORIC Oric Pharmaceuticals, Inc.
29 Mar 2021
Director
Sold, plan not stated
75,555
$1.76M
3.3%
ORIC Oric Pharmaceuticals, Inc.
26 Mar 2021
Director
Sold, plan not stated
27,816
$664.25K
1.2%
ORIC Oric Pharmaceuticals, Inc.
25 Mar 2021
Director
Sold, plan not stated
51,523
$1.27M
2.2%
ORIC Oric Pharmaceuticals, Inc.
24 Mar 2021
Director
Sold, plan not stated
32,959
$817.38K
1.4%
ORIC Oric Pharmaceuticals, Inc.
23 Mar 2021
Director
Sold, plan not stated
3,992
$97.09K
0.2%
ORIC Oric Pharmaceuticals, Inc.
22 Mar 2021
Director
Sold, plan not stated
7,673
$203.10K
0.3%
ORIC Oric Pharmaceuticals, Inc.
19 Mar 2021
Director
Sold, plan not stated
21,275
$563.15K
0.9%
ORIC Oric Pharmaceuticals, Inc.
18 Mar 2021
Director
Sold, plan not stated
6,059
$169.83K
0.2%
ORIC Oric Pharmaceuticals, Inc.
17 Mar 2021
Director
Sold, plan not stated
18,790
$534.20K
0.8%
ORIC Oric Pharmaceuticals, Inc.
16 Mar 2021
Director
Sold, plan not stated
41,353
$1.15M
1.6%
ORIC Oric Pharmaceuticals, Inc.
15 Mar 2021
Director
Sold, plan not stated
89,210
$2.60M
3.4%
ORIC Oric Pharmaceuticals, Inc.
12 Mar 2021
Director
Sold, plan not stated
90,521
$2.74M
3.3%
ORIC Oric Pharmaceuticals, Inc.
11 Mar 2021
Director
Sold, plan not stated
58,551
$1.93M
2.1%
CMPX Compass Therapeutics, Inc.
19 Jun 2020
Director
Bought
1,455,132
$7.28M
12.9%
ORIC Oric Pharmaceuticals, Inc.
24 Apr 2020
Director
Bought
281,250
$4.50M
opened
KROS Keros Therapeutics, Inc.
13 Apr 2020
Director
Bought
375,200
$6.00M
50.4%
ALEC Alector, Inc.
11 Feb 2019
Director
Bought
411,700
$7.82M
4.1%
XFOR X4 Pharmaceuticals, Inc
20 Nov 2017
Director
Bought
500,000
$5.00M
36.5%
RNAC Cartesian Therapeutics, Inc.
27 Jun 2016
Director
Bought
550,000
$7.70M
43.1%
NTLA Intellia Therapeutics, Inc.
11 May 2016
Director
Bought
250,000
$4.50M
10.4%
AMRN AMARIN CORP PLC\UK
4 Sep 2012
Director
Sold, plan not stated
233,700
$3.37M
97.6%
AMRN AMARIN CORP PLC\UK
27 Jul 2012
Director
Sold, plan not stated
366,300
$5.35M
97.9%
AMRN AMARIN CORP PLC\UK
19 Jun 2012
Director
Sold, plan not stated
617,100
$7.99M
98.2%
AMRN AMARIN CORP PLC\UK
2 May 2011
Director
Sold, plan not stated
32,900
$536.27K
65.5%
AMRN AMARIN CORP PLC\UK
29 Apr 2011
Director
Sold, plan not stated
100,000
$1.60M
85.0%
AMRN AMARIN CORP PLC\UK
21 Apr 2011
Director
Sold, plan not stated
750,000
$12.50M
97.6%
AMRN AMARIN CORP PLC\UK
20 Apr 2011
Director
Sold, plan not stated
800,000
$12.63M
96.9%
AMRN AMARIN CORP PLC\UK
18 Apr 2011
Director
Sold, plan not stated
3,000,000
$45.55M
98.9%
AMRN AMARIN CORP PLC\UK
28 Mar 2011
Director
Sold, plan not stated
93,100
$684.29K
60.2%
AMRN AMARIN CORP PLC\UK
25 Mar 2011
Director
Sold, plan not stated
56,900
$425.04K
47.7%
AMRN AMARIN CORP PLC\UK
24 Mar 2011
Director
Sold, plan not stated
23,000
$172.50K
26.8%
AMRN AMARIN CORP PLC\UK
21 Mar 2011
Director
Sold, plan not stated
77,000
$542.85K
55.0%
AMRN AMARIN CORP PLC\UK
15 Mar 2011
Director
Sold, plan not stated
50,000
$362.00K
43.9%
AMRN AMARIN CORP PLC\UK
14 Mar 2011
Director
Sold, plan not stated
75,000
$549.75K
53.8%
AMRN AMARIN CORP PLC\UK
11 Mar 2011
Director
Sold, plan not stated
100,000
$743.00K
60.6%
AMRN AMARIN CORP PLC\UK
7 Mar 2011
Director
Sold, plan not stated
25,000
$192.00K
27.5%
AMRN AMARIN CORP PLC\UK
4 Mar 2011
Director
Sold, plan not stated
43,000
$327.66K
39.4%
AMRN AMARIN CORP PLC\UK
3 Mar 2011
Director
Sold, plan not stated
7,000
$54.32K
9.5%
AMRN AMARIN CORP PLC\UK
2 Mar 2011
Director
Sold, plan not stated
95,000
$733.40K
58.8%
AMRN AMARIN CORP PLC\UK
1 Mar 2011
Director
Sold, plan not stated
50,000
$378.00K
42.6%
AMRN AMARIN CORP PLC\UK
28 Feb 2011
Director
Sold, plan not stated
100,000
$773.00K
59.5%
PCRX Pacira BioSciences, Inc.
8 Feb 2011
Director
Bought
535,714
$3.75M
23.4%
61 decisions on file.